Bremelanotide: An Overview of Preclinical CNS Effects on Female Sexual Function

To the extent that solicitations indicate the desire of female rats to engage in sexual activity, bremelanotide appears to possess the behavioral, pharmacological, and neuroanatomical specificity required of a drug in the treatment of hypoactive sexual desire disorders. Pfaus J, Giuliano F, and Gelez H. Bremelanotide: An overview of preclinical CNS effects on female sexual function.